{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:29:56Z","timestamp":1791066596904,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000965","name":"American Federation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000965","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Investigator Award 2011"},{"DOI":"10.13039\/100000957","name":"Alzheimer\u05f3s Association","doi-asserted-by":"publisher","award":["NIRG-11-205083"],"award-info":[{"award-number":["NIRG-11-205083"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","award":["R01 AG034087"],"award-info":[{"award-number":["R01 AG034087"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.euroneuro.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T09:17:41Z","timestamp":1400059061000},"page":"1303-1308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes"],"prefix":"10.1016","volume":"24","author":[{"given":"Ramit","family":"Ravona-Springer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Schmeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Koifman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal Schnaider","family":"Beeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.euroneuro.2014.05.001_bib1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.03.013","article-title":"APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline","volume":"22","author":"Bangen","year":"2013","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000342778","article-title":"Apolipoprotein E and change in episodic memory in blacks and whites","volume":"40","author":"Barnes","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3233\/JAD-2009-1160","article-title":"Impact of APOE epsilon4 on the cognitive performance of a sample of non-demented Puerto Rican nonagenarians","volume":"18","author":"Carrion-Baralt","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1212\/WNL.0b013e318211c3ae","article-title":"Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes","volume":"76","author":"Caselli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib5","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00125-009-1497-2","article-title":"Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study","volume":"52","author":"Dore","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib6","first-page":"379","article-title":"Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer\u05f3s Disease","volume":"8","author":"Fillenbaum","year":"1996","journal-title":"Aging"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.282.1.40","article-title":"The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons","volume":"282","author":"Haan","year":"1999","journal-title":"J. AM. Med. Assoc."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000067947","article-title":"Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes","volume":"49","author":"Hewer","year":"2003","journal-title":"Gerontology"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.diabres.2005.07.002","article-title":"The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization","volume":"71","author":"Heymann","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2010.08.063","article-title":"Diabetes, related conditions, and dementia","volume":"299","author":"Luchsinger","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib15","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/geronj\/48.4.M117","article-title":"The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes","volume":"48","author":"Meneilly","year":"1993","journal-title":"J. Gerontol."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib16","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib17","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.neurobiolaging.2013.06.002","article-title":"Substantial effects of apolipoprotein E epsilon4 on memory decline in very old age: longitudinal findings from a population-based sample","volume":"34","author":"Praetorius","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib18","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2337\/dc12-2250","article-title":"Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes","volume":"36","author":"Ravona-Springer","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib19","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1586\/ern.11.152","article-title":"The association of diabetes and dementia and possible implications for nondiabetic populations","volume":"11","author":"Ravona-Springer","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.euroneuro.2014.05.001_bib20","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib21","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s00125-012-2572-7","article-title":"HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2","volume":"55","author":"Sugawara","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib22","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1161\/STROKEAHA.113.000947","article-title":"Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study","volume":"44","author":"Weinstein","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.euroneuro.2014.05.001_bib23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneurol.2012.1117","article-title":"Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia","volume":"69","author":"Yaffe","year":"2012","journal-title":"Arch. Neurol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T08:50:54Z","timestamp":1565427054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0924977X14001394"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.05.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}